✦Canada Post Xpress1–2 day delivery across CanadaFree on orders over $200
Your cart is empty
Janoshik
Batch 51Q-CA-26A-01
Nicotinamide N-Methyltransferase (NNMT) Inhibitor Research Compound
5-Amino-1MQ is a small-molecule compound commonly studied in laboratory research for its interaction with enzymes involved in cellular metabolism. Researchers examine its role in pathways related to NAD⁺ regulation and energy utilization at the cellular level. It is frequently used in biochemical and metabolic pathway studies.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
5-Amino-1MQ is a small-molecule research compound studied as an inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in cellular metabolic regulation. It is developed for controlled laboratory investigation within experimental environments.
In scientific literature, 5-Amino-1MQ is examined in models evaluating NNMT-associated metabolic pathways, methylation-related signaling systems, and intracellular regulatory mechanisms under in vitro and preclinical research conditions.
5-Amino-1MQ is evaluated in research focused on NNMT pathway modulation and metabolic signaling systems. Experimental studies examine its interaction with enzymatic regulatory frameworks and intracellular methylation-associated processes within controlled laboratory environments.
Research publications have explored its biochemical interaction profile and pathway-level signaling characteristics under structured experimental conditions.
Research into NNMT as a metabolic regulatory enzyme led to the development of small-molecule inhibitors such as 5-Amino-1MQ. Investigations into enzymatic pathway modulation expanded into laboratory models evaluating metabolic regulation and intracellular signaling systems.
Subsequent studies documented its interaction with NNMT-related pathways in controlled experimental frameworks.
Laboratory investigations into 5-Amino-1MQ have focused on NNMT inhibition models and metabolic pathway regulation systems. Research frameworks evaluate enzymatic interaction dynamics, methylation-associated processes, and intracellular regulatory mechanisms under controlled in vitro and preclinical conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each vial contains 10mg of 5-Amino-1MQ. Independent third-party testing verifies purity, identity, and net content per batch.
The vial contains only the compound. Any laboratory materials required for experimental procedures must be sourced separately.
Duration depends entirely on research protocol, storage conditions, and laboratory application.
Related
Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$180.00
Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$10.00
Immune-modulating peptide studied for T-cell signaling and immune system regulatory pathway research
From$70.00
GHRH analog studied for growth hormone regulation and metabolic pathway signaling research
From$95.00
